Zobrazeno 1 - 10 of 1 559 pro vyhledávání: '"Alb M"'
1
Akademický článek
Cellular Therapies for Multiple Myeloma: Engineering Hope.
Autor: Vera-Cruz S; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany., Jornet Culubret M; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany., Konetzki V; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany., Alb M; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany., Friedel SR; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany., Hudecek M; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany.; Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Außenstelle Zelluläre Immuntherapie, 97080 Würzburg, Germany., Einsele H; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany., Danhof S; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany.; Mildred Scheel Early Career Center, Universitätsklinikum Würzburg, 97080 Würzburg, Germany., Scheller L; Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany.; Interdisziplinäres Zentrum für Klinische Forschung (IZKF), Universitätsklinikum Würzburg, 97080 Würzburg, Germany.
Publikováno v: Cancers [Cancers (Basel)] 2024 Nov 19; Vol. 16 (22). Date of Electronic Publication: 2024 Nov 19.
Zobrazit plný text záznamu
2
Akademický článek
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept.
Autor: Alb M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, Würzburg, Germany., Reiche K; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Rade M; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Sewald K; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM, Hannover, Germany., Loskill P; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen.; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Cipriano M; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen., Maulana TI; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen., van der Meer AD; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Weener HJ; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Clerbaux LA; European Commission, Joint Research Centre (JRC), Ispra, Italy., Fogal B; Department on Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceutical, Inc, Ridgefield, CT, USA., Patel N; Preclinical Safety, Research and Development, Sanofi-Aventis US, LLC, Cambridge, MA, USA., Adkins K; Preclinical Safety, Research and Development, Sanofi-Aventis US, LLC, Cambridge, MA, USA., Lund E; Labcorp Drug Development Inc, Derbyshire, UK., Perkins E; Labcorp Drug Development Inc, Derbyshire, UK., Cooper C; Labcorp Drug Development Inc, Derbyshire, UK., van den Brulle J; T-CURX GmbH, Würzburg, Germany., Morgan H; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Rubic-Schneider T; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Ling H; Novartis Biomedical Research, Cambridge, MA, USA., DiPetrillo K; Novartis Biomedical Research, Cambridge, MA, USA., Moggs J; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Köhl U; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Hudecek M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, Würzburg, Germany.; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany.
Publikováno v: Journal of immunotoxicology [J Immunotoxicol] 2024 Oct; Vol. 21 (sup1), pp. S13-S28. Date of Electronic Publication: 2024 Dec 10.
Zobrazit plný text záznamu
3
Akademický článek
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.
Autor: Mazein A; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg., Shoaib M; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg., Alb M; Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Würzburg, Germany., Sakellariou C; Department of Immunotechnology, Lund University, Lund, Sweden., Sommer C; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Preclinical Pharmacology and In-Vitro Toxicology, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Sewald K; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Preclinical Pharmacology and In-Vitro Toxicology, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Reiche K; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany., Gogesch P; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany., Roser LA; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany., Ortega Iannazzo S; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany., Sheth S; BioSci Consulting, Maasmechelen, Belgium., Schiffmann S; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany., Waibler Z; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany., Neuhaus V; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Preclinical Pharmacology and In-Vitro Toxicology, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Dehmel S; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Preclinical Pharmacology and In-Vitro Toxicology, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Satagopam V; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.; ELIXIR Luxembourg, Belvaux, Luxembourg., Schneider R; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.; ELIXIR Luxembourg, Belvaux, Luxembourg., Ostaszewski M; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.; ELIXIR Luxembourg, Belvaux, Luxembourg., Gu W; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.; ELIXIR Luxembourg, Belvaux, Luxembourg.
Publikováno v: Journal of immunotoxicology [J Immunotoxicol] 2024 Oct; Vol. 21 (sup1), pp. S5-S12. Date of Electronic Publication: 2024 Dec 10.
Zobrazit plný text záznamu
4
Akademický článek
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assay.
Autor: Dinh-Le T; Sanofi, Global Human Immunology, Orlando, FL, USA., Escobar J; Sanofi, Global Human Immunology, Orlando, FL, USA., Poisson L; Sanofi, Global Human Immunology, Orlando, FL, USA., Adkins K; Sanofi, Pre-Clinical Safety, Cambridge, MA, USA., Jornet Culubret M; Department of Internal Medicine II, Chair of Cellular Immunotherapy, University Hospital Wurzburg, Wurzburg, Germany., Scheller L; Department of Internal Medicine II, Chair of Cellular Immunotherapy, University Hospital Wurzburg, Wurzburg, Germany., van den Brulle J; T-CURX GmbH, Würzburg, Germany., Hudecek M; Department of Internal Medicine II, Chair of Cellular Immunotherapy, University Hospital Wurzburg, Wurzburg, Germany.; Fraunhofer-Institut für Zelltherapie und Immunologie, Außenstelle Würzburg Zelluläre Immuntherapie, Würzburg, Germany., Drake Iii DR; Sanofi, Global Human Immunology, Orlando, FL, USA., Alb M; Department of Internal Medicine II, Chair of Cellular Immunotherapy, University Hospital Wurzburg, Wurzburg, Germany., Luna E; Sanofi, Global Human Immunology, Orlando, FL, USA.
Publikováno v: Journal of immunotoxicology [J Immunotoxicol] 2024 Oct; Vol. 21 (sup1), pp. S29-S37. Date of Electronic Publication: 2024 Dec 10.
Zobrazit plný text záznamu
5
Review
Luther und Luthertum in der ersten Entwicklung. Bd. 2 Heinrich Denifle Alb. M. Weiß
Autor: Köhler, W.
Publikováno v: Historische Zeitschrift, 1911 Jan 01. 106(1), 136-139.
Externí odkaz: https://www.jstor.org/stable/27602692
Zobrazit plný text záznamu
6
Akademický článek
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells.
Autor: Maulana TI; Department of Microphysiological Systems, Institute of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University-Tübingen, 72074 Tübingen, Germany; NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany., Teufel C; Department of Microphysiological Systems, Institute of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University-Tübingen, 72074 Tübingen, Germany., Cipriano M; Department of Microphysiological Systems, Institute of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University-Tübingen, 72074 Tübingen, Germany; 3R Center Tübingen for In Vitro Models and Alternatives to Animal Testing, 72074 Tübingen, Germany., Roosz J; NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany., Lazarevski L; Department of Microphysiological Systems, Institute of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University-Tübingen, 72074 Tübingen, Germany., van den Hil FE; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands., Scheller L; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, 97078 Würzburg, Germany., Orlova V; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands., Koch A; Department of Women's Health Tübingen, Eberhard Karls University-Tübingen, 72076 Tübingen, Germany., Hudecek M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, 97078 Würzburg, Germany; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Außenstelle Würzburg Zelluläre Immuntherapie, 97082 Würzburg, Germany., Alb M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, 97078 Würzburg, Germany. Electronic address: alb_m@ukw.de., Loskill P; Department of Microphysiological Systems, Institute of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University-Tübingen, 72074 Tübingen, Germany; NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany; 3R Center Tübingen for In Vitro Models and Alternatives to Animal Testing, 72074 Tübingen, Germany. Electronic address: peter.loskill@uni-tuebingen.de.
Publikováno v: Cell stem cell [Cell Stem Cell] 2024 Jul 05; Vol. 31 (7), pp. 989-1002.e9. Date of Electronic Publication: 2024 May 15.
Zobrazit plný text záznamu
7
Akademický článek
Restoration of the ER stress response protein TDAG51 in hepatocytes mitigates NAFLD in mice.
Autor: Yousof TR; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Bouchard CC; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Alb M; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Lynn EG; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Lhoták S; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Jiang H; Department of Pediatrics, School of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA., MacDonald M; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Li H; Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA., Byun JH; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Makda Y; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada., Athanasopoulos M; Department of Biology, McMaster University, Hamilton, Ontario, Canada., Maclean KN; Department of Pediatrics, School of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA., Cherrington NJ; Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA., Naqvi A; Department of Pathology and Molecular Medicine, St. Joseph's Healthcare Hamilton, McMaster University, Hamilton, Ontario, Canada., Igdoura SA; Department of Biology, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada., Krepinsky JC; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada., Steinberg GR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada; Division of Endocrinology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Austin RC; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. Electronic address: austinr@taari.ca.
Publikováno v: The Journal of biological chemistry [J Biol Chem] 2024 Feb; Vol. 300 (2), pp. 105655. Date of Electronic Publication: 2024 Jan 16.
Zobrazit plný text záznamu
8
Akademický článek
Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways.
Autor: Clerbaux LA; European Commission, Joint Research Centre (JRC), Ispra, Italy., Filipovska J; Independent scientist, Ohrid, North Macedonia., Nymark P; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Chauhan V; Consumer and Clinical Radiation Protection Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Canada., Sewald K; Fraunhofer ITEM, Hannover, Germany, Member of DZL BREATH., Alb M; Medizinische Klinik und Poliklinik II, Würzburg, Germany., Sachana M; OECD, Paris, France., Beronius A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Amorim MJ; Católica Medical School, Católica Biomedical Research Centre, Universidade Católica Portuguesa, Lisboa, Portugal.; Instituto Gulbenkian de Ciência, Fundação Calouste Gulbenkian, Oeiras, Portugal., Wittwehr C; European Commission, Joint Research Centre (JRC), Ispra, Italy.
Publikováno v: ALTEX [ALTEX] 2024; Vol. 41 (2), pp. 233-247. Date of Electronic Publication: 2023 Nov 17.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje